This study describes six generations of a family with autosomal dominant cardiac conduction system and myocardial disease with recognizable clinical stages. A 20 year follow-up of nine family members, a medical questionnaire of 196, electrocardiographic screening of 91, noninvasive testing of 20, and catheterization with endomyocardial biopsy of six are the basis of this report. The clinical stages are as follows: Stage I occurs in the second and third decades of life and is characterized by an absence of symptoms, normal heart size, sinus bradycardia, and premature atrial contractions. Stage II is marked by first-degree atrioventricular block in the third and fourth decades. Stage III occurs in the fourth and fifth decades and is accompanied by chest pain, fatigue, lightheadedness, and advanced atrioventricular block followed by the development of atrial fibrillation or flutter. Stage IV, in the fifth and sixth decades of life, is characterized by congestive heart failure and recurrent ventricular arrhythmias. Light microscopy of right ventricular endomyocardial biopsy specimens from patients in stage II revealed very mild fibrosis; electron microscopy of the specimens demonstrated mild dilatation of tubules, mitochondrial swelling, and minimal myofibrillar loss. Biopsy specimens from patients with stage III disease were similar to those from patients with stage IL disease except for an increase of myofibrillar loss. The stage IV specimens had diffuse fibrosis and more severe tubular dilatation, mitochondrial cristolysis, and myofibrillar loss. At autopsy in the proband, the atrial changes were more severe than the ventricular and were especially marked in the sinoatrial and atrial myocardium. Early recognition of the disease and use of pacemakers and antiarrhythmic agents have proved beneficial for affected family members. Thorough family studies of patients with conduction system disease and/or dilated cardiomyopathy are necessary to better understand the hereditary basis and natural course of this category of disease. Circulation 74, No. 1, 21-35, 1986. 
identifiable features has been widely recognized.3 '- The purpose of this report is to describe cardiac functional and histologic characteristics in a large family affected by a combination of conduction system disease and dilated cardiomyopathy.
Methods
Recognition of the familial disorder developed gradually during the 9 years of the medical care of the proband and prompted further evaluation of other family members (entire family presented in figure 1 ). During this time, detailed information was obtained from nine family members who received medical treatment, pacemakers, or both at University Hospital during the past 20 years.
A medical questionnaire was sent to 196 family members of generations IV through VI shown in figure 1 . The questionnaire specifically asked about the symptoms of dyspnea, palpitations, lightheadedness, chest pain, and peripheral edema. The questionnaire also was directed at finding other family members not yet known to the investigators. Any prior cardiac information such as electrocardiograms and echocardiograms was sought. The results of the questionnaire led us to obtain electrocardiograms in 91 family members (ages 7 to 66 years). The electrocardiograms were obtained with a Marquette 2000 electrocardiograph. Rhythm was recorded by a 1 min rhythm strip. The measurement of intervals (PR, QRS, and QT) was performed by one of us (H. G.). Nineteen family members who had electrocardiograms that showed premature atrial contractions, sinus bradycardia, or a prolonged PR interval, or a history that was positive for chest pain, palpitations, fatigue, lightheadedness, or dyspnea, had a complete clinical evaluation, including history and physical examination and an echocardiogram.
Echocardiography was performed with a Unirad Series C ultrasonoscope and an Electronics for Medicine VR6 recorder or an SK Echoline 20A echocardiograph with an Irex recorder. Echocardiographic interpretation was performed in accordance with the recommendations of the American Society of Echocardiography. 12 The change in the minor axis of the left ventricle with systole was the echocardiographic determinant of left ventricular function. The end-diastolic diameter of the left ventricle and the left ventricular free wall thickness were also recorded. Reproducibility of these tests in our laboratory has been determined previously. 13 A right ventricular endomyocardial biopsy procedure14 was performed through the right internal jugular vein. Each sample used for study was 1 to 2 mm3 and weighed 1 to 4 mg. One piece of tissue was placed in 2% buffered glutaraldehyde (pH 7.35) washed in 0. 1M phosphate buffer (pH 7.35), minced into five or six pieces, postfixed in osmium tetroxide, and embedded in Spurr embedding resin. One-micrometer thick sections stained 22 with toluidine blue were examined and two blocks with longitudinally oriented fibers were selected for electron microscopy. Thin sections (60 to 90 nm) were stained with Reynolds lead citrate and uranyl acetate and examined on a Hitachi HU 12 transmission electron microscope independently by two pathologists (N. B. and P. B.). Tissue was compared with that of normal subjects and of cardiomyopathic subjects as previously reported by our laboratory. 15. 16 At least two other pieces of tissue were placed in buffered 10% formalin. Light microscopic slides 3 to 5 ,gm thick were prepared from paraffln-embedded sections. The slides were stained with hematoxylin-eosin and Masson's trichrome stains by the methods of Sheehan and Hrapchak. 7 The methods have been previously reported by our laboratory. 18' 19 The proband died of ventricular fibrillation, and an autopsy with gross, light, and electron microscopic evaluation of the heart was performed. This study was approved by the Institutional Human Subjects Review Committee, and all patients gave written informed consent.
Results
Proband. The proband and his immediate family presented many facets common to the entire family and are presented in greater detail. The proband, a white male farmer, was 48 years old when first seen in 1969; he presented with the complaint of chest pain and a 7 year history of a slow heart rate. His blood pressure was 140/88 mm Hg and his heart rate was 42 beats/ CIRCULATION min. A grade JIL/VI mitral regurgitation murmur was present with a left ventricular S3 sound. The electrocardiogram showed complete atrioventricular (AV) block with a normal QRS interval; a chest roentgenogram showed a cardiothoracic ratio of 0.5 1 with a prominent left ventricle. He returned to his usual activities until 1974, when he experienced increased fatigue and chest pain. The electrocardiogram showed atrial flutter and complete AV block with a normal QRS interval; the chest roentgenogram revealed cardiomegaly (cardiothoracic ratio 0.60). Cardiac catheterization showed normal coronary artery anatomy, diffuse left ventricular hypokinesis, and a reduced left ventricular ejection fraction of 30%. Pacemaker therapy was initiated with a left ventricular epicardial demand pacemaker. A left atrial appendage biopsy specimen obtained at surgery demonstrated fibrosis and scattered cellular necrosis. Ultrastructural examination showed a variety of myopathic alterations with increased lipofuscin pigment, fat droplets, and dilated sarcoplasmic reticulum.
The clinical course from 1974 to 1977 was characterized by the gradual development of biventricular failure, frequent premature ventricular beats and persistence of the atrial flutter. Multiple antiarrhythmic agents were used in combination with the pacemaker. An in-hospital episode of abrupt onset ventricular tachycardia and fibrillation responded to cardiopulmonary resuscitation. Three months later, the patient died suddenly at age 57 from ventricular arrhythmias.
At autopsy, the heart weighed 600 g. There was combined dilatation and hypertrophy of all chambers and scattered endocardial fibrosis. The atria and the sinus node were diffusely fibrotic. The AV node was unremarkable except for mild fatty infiltration. Patchy subendocardial fibrosis in the ventricular septum involved the conduction bundles (figure 2). Multiple foci of interstitial fibrosis with mixed hypertrophy and atrophy of the muscle cells characterized the ventricles (figure 3). The coronary arteries showed minimal plaque disease.
Proband's immediate family. The proband's mother had a history of a slow heart rate for many years and died suddenly at age 49. A younger brother, 45 years old at the time of his initial evaluation in 1975, had exertional chest pain, a history of a heart murmur and palpitations since age 20, and a grade IT/VI mitral regurgitation murmur. His chest roentgenogram showed a normal cardiac silhouette. The electrocardiogram showed premature atrial contractions, prolonged PR interval, a normal QRS interval, and a heart rate of 56 beats/min. Three years later, at age 48, he noticed a slow heart rate and fatigue. An electrocardiogram was characterized by intermittent firstand second-degree AV block and a ventricular rate of 45 beats/min; spontaneous atrial flutter was also recorded. After cardiac catheterization (normal coronary artery anatomy and diffuse ventricular hypokinesis), pacemaker therapy was initiated with a left ventricular epicardial demand pacemaker. A biopsy specimen from the left atrial appendage showed fibrosis and scattered cellular necrosis. Ultrastructural examination showed myopathic alterations with increased lipofuscin pigment, fat droplets, and dilated sarcoplasmic reticulum. To date, the clinical course has been quite similar to the proband's; at age 50 he experienced chest pain, exertional dyspnea, and required antiarrhythmic therapy for the control of ventricular arrhythmias. Cardiomegaly was documented by chest roentgenogram. The generation and patient number are the same as figure The proband's daughter, 27 years old when first seen, had a history of palpitations and a normal resting electrocardiogram. At age 30 she developed chest pain, was noted to have a mitral regurgitation murmur and echocardiographically documented mitral valve prolapse. Frequent premature atrial and premature ventricular contractions were noted during a treadmill exercise electrocardiogram.
The proband's niece, 15 years old when first seen, had a history of palpitations and a rapid heart rate, sinus tachycardia with premature atrial contractions, a mitral regurgitation murmur, and an echocardiogram consistent with mitral valve prolapse. At age 20 she had intermittent sinus bradycardia.
A sibling of the proband's niece had a normal electrocardiogram at age 12. She developed an awareness of irregular heart rhythm at age 17; an ambulatory 24 hr electrocardiogram showed intermittent AV block (Mobitz Type I) and sinus bradycardia.
Family study: family tree. The family was of German origin. A family geneology reference book, with information dating to 1803, was used to establish a complete family tree from the descendants of the second of nine original children (figure 1). All of the patients presented in the present study are offspring of sibling Vol. 74, No. 1, July 1986 2. Siblings 1 and 6 were probably affected, but data are incomplete and will not be presented.
Cardiovascular deaths and electrocardiographic findings of affected members from descendants of siblings 1, 3, 4, 11, and 12 of generation III are shown. Members 9 and 17 of generation IV, and members 6, 9, and 10 of generation V were not examined but had histories of a slow heart rate with sudden deaths at an average age of 48 years.
Certain descendants from the second, fifth, sixth, eighth, ninth, tenth, and thirteenth siblings of generation III (the seventh died in infancy) appear to have been affected; however, data are incomplete and will not be presented.
Members with pacemakers. Ten members from generations IV and V were treated with pacemakers; nine are included in this report. Five patients were symptomatic with advanced conduction system disease when first seen requiring immediate pacemaker therapy, while the remaining four members had been seen at an earlier stage of their disease and required pacemaker therapy at a later date. A historical sketch of symptoms, electrocardiograms, and chest roentgenograms on initial presentation, and progression of clinical disease are presented in table 1.
Family members affected at an early age. Twenty family members from generations V and VI appear to have been affected at an early age. Two were first cousins of the proband; 18 were direct offspring of affected members with pacemakers. The results of their histories, physical examinations, electrocardiograms, and echocardiograms are presented in table 2.
Clinical evolution. The results of the clinical evaluation as detailed above led to a staging of this disease. The evolution of the disease (table 3) appears to be as follows: Stage I was generally recognized in the second and third decades of life; affected members were asymptomatic and had normal heart size with premature atrial contractions and sinus bradycardia. A mitral regurgitation murmur associated with mitral valve prolapse was a common finding. Stage II was marked by the onset of symptoms in the third and fourth decades, normal heart size on chest roentgenogram and evidence of first-degree AV block. Stage III occurred in the fourth and fifth decades with chest pain, fatigue, lightheadedness, and awareness of a slow heart rate; advanced AV block was frequently associated with or followed by the development of atrial flutter or fibrillation. Stage IV, in the fifth and sixth decades, was characterized by congestive heart failure, thromboembolic events, and recurrent ventricular arrhythmias.
Survival in stages III and IV appears to be related to 25 and modified by either pacemaker therapy or antiarrhythmic agents. Five sudden deaths in generations four and five, before recognition of the disease process and before pacemaker and medical therapy, occurred at an average age of 47.8 years (range 42 to 50 years), while the average age of death in five family members (table 4) . To date, none of the stage I patients have undergone a myocardial biopsy. A biopsy specimen from one patient with stage II disease revealed mild fibrosis with mild sarcoplasmic reticular, mitochondrial, and myofibrillar changes. Four subjects with stage III disease had mild fibrosis but more diffuse and severe dilatation of sarcoplasmic reticulum and mitochondrial degeneration (figure 4) and mild myofibrillar loss ( figure 5 ). Myocardial biopsy of two patients with stage IV disease revealed diffuse fibrosis, more severe mitochondrial swelling with cristolysis, and moderate myofibrillar loss ( figure 6 ).
Discussion
This report, based on a partial pedigree of six generations dating back to 1803, presents a family with a hereditary cardiac conduction system and cardiac mus-CIRCULATION cle disease with an autosomal dominant pattern of inheritance. Certain family members have been followed for more than 20 years, permitting observations on the progression through clinical stages of this disease. Subtle atrial arrhythmias are an early clinical indicator of the atrial cardiomyopathic disease process. The gradual progression to AV block with chronic atrial arrhythmias and the eventual development of congestive heart failure and recurrent ventricular arrhythmias characterize the later stages. The pedigree demonstrates autosomal dominant inheritance with direct transmission between generations. The severity and Autosomal dominant inheritance has been demonstrated for familial cardiac conduction system disease,3 familial cardiac arrhythmias, 2023 and familial dilated cardiomyopathy. --7 Several reports have included families with a combination of dilated cardiomyopathy with arrhythmias or conduction diseases.25"3 Some studies have found a pattern of autosomal recessive inheritance in families with dilated cardiomyopathy.28-30 Despite these reports, the basis for classification of these entities is incomplete and 28 the pathophysiology is unclear. Although "primary" conduction system and "primary" myocardial disease are frequently presented as separate, discrete entities, these pathologic processes are joined in the family presented. It is unclear, however, whether familial cardiac conduction system disease is a specific entity or represents a form of diffuse cardiomyopathy.
Pathologic findings. This study has permnitted the analysis of myocardial histologic changes in patients before they have developed overt heart failure as well as during both mild and severe heart failure. Degenerative changes (mild fibrosis, swelling of mitochondria CIRCULATION FIGURE 6. Electron micrograph of a biopsy specimen from a patient in clinical stage IV. There is moderate to mild myofibrillar loss (asterisks) and marked increase of lipofuscin (L). The nucleus and nucleolus (arrow) appear normal. ( x 6400.) and sarcoplasmic reticulum, and mild myofibrillar loss) occurred while ventricular function remained normal. Each of the pathologic alterations listed in table 4 worsened with the development of clinical congestive heart failure. This evidence strongly supports the hypothesis that the cardiac histologic abnormalities are a cause and not a result of the hemodynamic abnormalities of congestive heart failure. The histologic changes that result after severe heart failure has developed may well be a combination of primary and secondary abnormalities. In addition, the pathologic changes recorded at the autopsy of the proband clearly show that the atria are more severely involved than the ventricles in the present family study.
Biochemical considerations. Metabolic abnormalities have been reported in human subjects with heart failure. Three separate families have been reported3'"to have a deficiency of carnitine associated with heart failure; subsequent improvement of their cardiomyopathy occurs with carnitine repletion. Carnitine, a cofactor in the system that transports fatty acids across the inner mitochondrial membrane, is present in the diet but is also synthesized in the kidney and liver.
Deficiency of carnitine inhibits the transportation and oxidation of the fatty acids by mitochondria with a resultant accumulation of lipid in the cytosol. Cardiac muscle is dependent on the oxidation of fatty acids for most of its energy; loss of this source severely affects myocardial performance.
Preliminary studies from our laboratory of the myocardial ATPase activities in endomyocardial biopsy specimens have suggested that Ca'-ATPase activity may be depressed in familial dilated cardiomyopathy.3< Only three family members have had their biop sy specimens evaluated for Cat +-ATPase activity, but these three have had the lowest activities of this enzyme of the total of 32 patients evaluated to the present time. The 32 patients in that study included normal subjects as well as patients with familial and idiopathic dilated cardiomyopathy.34 Further biochemical investigations of this family are planned.
The difficulties in finding molecular-level explanations for dominantly inherited disorders have been discussed by Brock.35 However, he considered the concept that an abnormality in a membrane protein might give rise to a dominantly inherited disorder to be an Vol. 74, No. 1, July 1986 29 attractive one. Further natural history, electrophysiologic, histochemical, and metabolic studies in familial conduction system and myocardial disease will be necessary to evaluate these postulates.
Animal preparations of familial cardiomyopathy. Several animal preparations have been developed that mimic the clinical, pathologic, and possibly the biochemical characteristics of the family presented in this study. The Syrian hamster preparation of congestive cardiomyopathy, in which a genetic defect leads to malformation of the cardiac membranous systems, provides an interesting and provocative basis for comparison.3639 It has been proposed that the primary defect in the cardiac membrane composition leads to altered cation permeability before cardiac tissue necrosis and fibrosis. The observation that an excitation-contraction coupling defect occurs before reduction of cardiac contractility and overt signs of cardiomyopathy develop39 suggests a temporal sequence in the animal preparation similar to our clinical observations. Thus an animal model of cardiomyopathy does exist for genetic cardiac disease with progressive abnormalities in excitation-contraction that precede abnormalities of cardiac contractility.
Round heart disease, a naturally occurring cardiomyopathy in inbred turkeys, is characterized by cardiac dilatation, poor systolic function, and electrical instability.40 Myocardial nuclear metabolism has been evaluated; nuclear protein phosphorylation is lower and the histone-to-nonhistone protein ratio is higher in spontaneously cardiomyopathic turkeys than in those with furazolidone-induced heart failure and in control turkeys.) 42 In addition, the metabolism of the sarcoplasmic reticulum was abnormal; calcium binding and uptake was depressed before the appearance of cardiac dilatation. Ca ++-ATPase activity was depressed after the development of heart failure.43 This preparation appears to resemble the present syndrome in its clinical characteristics and possibly in the abnormal handling of calcium by the sarcoplasmic reticulum. The basis for conduction system disease. The initiation and perpetuation of chronic atrial flutter and fibrillation has been reported in patients with normal left atrial size"4; prolonged intra-atrial and interatrial conduction abnormalities provided the electrophysiologic basis for the arrhythmias in that report. The authors postulated that an underlying fibrodegenerative conduction disease may be the cause of the conduction abnormality. 4 The areas of focal degeneration and necrosis of the atrial tissue in affected family members in the present study may provide the basis for the atrial arrhythmias and sinus bradycardia seen during stage I of this famil-ial disease. Progressive involvement of atrial and AV conduction tissue preceded the clinically recognizable evidence of ventricular myocardial involvement.
The electrophysiologic changes of atrial arrhythmias followed by a prolonged PR interval and then AV block and followed later by ventricular arrhythmias and ventricular conduction disease in familial cardiomyopathy contrast with the electrophysiologic characteristics in idiopathic dilated cardiomyopathy. In 115 patients with dilated cardiomyopathy previously reported from our laboratory,45 left ventricular conduction delay (in 63%) preceded AV nodal delay, and ventricular arrhythmias (90%) were more common than atrial arrhythmias (61%).46 Thus the progression of conduction disease from the atria to junctional tissues and then to the ventricles as well as the occurrence of atrial arrhythmias before ventricular arrhythmias in this family are not commonly seen in patients with idiopathic dilated cardiomyopathy. It is difficult then to relate the histologic and biochemical changes that may be seen in familial dilated cardiomyopathies to all cases of idiopathic dilated cardiomyopathy. Because of the heterogeneous nature of the idiopathic form, however, the familial form of the disease may represent a distinct subgroup of idiopathic dilated cardiomyopathy.
Summary. The present study and the growing bibliography in the area of familial cardiac conduction system and myocardial disease present a serious challenge to traditional pathologic, etiologic, and hemodynamic classifications. In addition, there are practical lessons that can be learned from the present study: (1) There must be an awareness that cardiac conduction system disease or dilated congestive cardiomyopathy may be familial; (2) electrocardiographic screening and ambulatory monitoring of family members are of great value in detecting subtle abnormalities; (3) detailed family studies and clinical evaluation of living family members are necessary to uncover inheritance patterns; (4) histologic abnormalities may be present during the interval when conduction system and myocardial disease are "subclinical"; and (5) dilated cardiomyopathy is a heterogeneous group of diseases with multiple etiologies and varying clinical course. Extensive biochemical investigation may provide clues to the etiology of familial cardiac conduction system and myocardial disease. ECG = electrocardiogram; WPW = Wolff-Parkinson-White syndrome; DC = dilated cardiomyopathy; HC = hypertrophic cardiomyopathy; SSS = sick sinus syndrome; CHF = congestive heart failure; CHB = complete heart block; ASCVD = asymptomatic cardiovascular disease; H/B = heart block; cmgy = cardiomegaly; LVE = left ventricular enlargement; RBBB = right bundle branch block; SR = sarcoplasmic reticulum; RV = right ventricle; SA = sinoatrial; MR = mitral regurgitation. 33 
